Eton Pharmaceuticals Chief Commercial Officer Ipek Erdogan-Trinkaus Reports Sale of 3,500 Common Shares for $235,937.218

• Eton Pharmaceuticals Chief Commercial Officer Ipek Erdogan-Trinkaus sold 3,500 common shares on Nov. 10, 2026.
• Sales comprised 2,340 shares at $67.1787 per share; another 1,160 shares sold at $67.8785 per share.
• She also exercised employee stock options for 3,500 common shares at $15.47 per share that day.
• Following the transactions, her direct holdings totaled 4,081 common shares and 37,155 employee stock options.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-036605), on November 12, 2026, and is solely responsible for the information contained therein.